106190 — High Tech Pharm Co Balance Sheet
0.000.00%
- KR₩129bn
- KR₩116bn
- KR₩78bn
- 50
- 65
- 12
- 35
Annual balance sheet for High Tech Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,038 | 12,637 | 7,880 | 5,365 | 7,759 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19,708 | 9,472 | 28,555 | 24,483 | 20,357 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 40,477 | 40,488 | 52,040 | 56,571 | 64,234 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 85,205 | 80,544 | 74,934 | 75,001 | 72,002 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 128,446 | 122,937 | 132,202 | 135,058 | 140,090 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26,933 | 22,703 | 31,738 | 22,785 | 18,946 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 33,302 | 29,052 | 32,263 | 28,064 | 20,352 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 95,144 | 93,885 | 99,939 | 106,994 | 119,738 |
| Total Liabilities & Shareholders' Equity | 128,446 | 122,937 | 132,202 | 135,058 | 140,090 |
| Total Common Shares Outstanding |